used in the
clinic although they cause several severe side effects and accumulate in tissues. Therefore
with properly assessment of
clinical and laboratorial findings.
Akhmetgaleyevaa, A.F.,
Khidiyatovaa, I.M.,
Saifullinac, E.V.,
Idrisovad, R.F.,
Magzhanov, R.V.,
Khusnutdinovaa, E.K. (2016) in
two unrelated families.
Clinical studies have shown that, in both families, the disease corresponds
Gareev, I,
Beylerli, O,
Wang, CL,
Sokhatskii, A,
Liang, YC,
Xiang, H,
Liu, CY,
Xu, X,
Guang, Y (2022) pathogenesis and discussed their potential
clinical application as non-invasive biomarkers.
Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) , the persisting deficiencies and future prospects of using lncRNAs as
clinical biomarkers and therapeutic targets
Zhandabayeva, MA,
Kozhanova, KK,
Boshkayeva, AK,
Kataev, VA,
Ustenova, GO,
Gemejiyeva, NG,
Iskakbayeva, ZA (2021) clinically significant microorganisms: Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa